PointState Capital’s MacroGenics MGNX Stock Holding History

PointState Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-375,000	Closed	-$13.2M	–	137
2014 Q4	$13.2M	Buy	375,000 +275,000	+275%	+$6.86M	0.22%	74
2014 Q3	$2.09M	Sell	100,000 -200,000	-67%	-$4.14M	0.04%	86
2014 Q2	$6.52M	Sell	300,000 -75,000	-20%	-$1.58M	0.08%	90
2014 Q1	$10.4M	Buy	375,000 +195,000	+108%	+$6.89M	0.17%	73
2013 Q4	$4.94M	Buy	+180,000	New	+$4.71M	0.06%	115

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

PointState Capital's MGNX Position: Q1 2015 in Review

PointState Capital sold out of MacroGenics (MGNX) in Q1 2015, closing a stake of 375,000 shares — an estimated $13.2M sold.

PointState Capital first reported a position in MGNX in Q4 2013 and held it in 5 quarters. The position peaked at $13.2M in Q4 2014. 113 funds tracked by Wall St. Rank hold MGNX as of Q1 2015.

PointState Capital reported no remaining MacroGenics position as of Q1 2015 after selling out during the quarter.
PointState Capital sold 375,000 MacroGenics shares in Q1 2015, an estimated $13.2M.
PointState Capital first reported a position in MacroGenics in Q4 2013 and held it in 5 quarters.
PointState Capital's MacroGenics position peaked at $13.2M in Q4 2014.
113 funds tracked by Wall St. Rank held MacroGenics as of Q1 2015.

Based on PointState Capital's 13F filing for Q1 2015, filed 15 May 2015.